中西药联合免疫调节剂对糖尿病合并肺结核患者的临床观察 |
| |
引用本文: | 余红军,罗方,张福生.中西药联合免疫调节剂对糖尿病合并肺结核患者的临床观察[J].中国现代医生,2011,49(1):3-5. |
| |
作者姓名: | 余红军 罗方 张福生 |
| |
作者单位: | 浙江省龙游县人民医院内三科,浙江,龙游,324400 |
| |
摘 要: | 目的探讨联合应用抗结核中西药和免疫调节剂对糖尿病合并肺结核患者免疫功能、痰菌阴转率、空洞闭合率及其临床疗效。方法将87例糖尿病合并肺结核患者分为对照组(44例)和治疗组(43例),对照组采用控制饮食、口服降糖药物的方法及2S(E)HRTJ4H3R3的化疗方案进行治疗;治疗组强化期上加服结核丸及免疫调节剂给予母牛分支杆菌菌苗,抗结核治疗2个月、6个月后对痰菌情况及空洞闭合情况进行对比分析,记录治疗前后T细胞亚群变化情况及其临床疗效。结果治疗后治疗组与对照组比较,CD4治疗后较治疗前明显上升(P〈0.05),CD8治疗后较治疗前明显下降(P〈O.05),CD4/CD8治疗后较治疗前明显上升(P〈O.05);痰菌转阴率比较:对照组和治疗组2个月末痰菌转阴率分别为61.36%和81.40%,与对照组比较存在显著性差异(P〈O.05),治疗6个月末治疗组和对照组分别为75.00%和93.02%,与对照组比较存在显著性差异(P〈0.05);空洞闭合率比较,与对照组比较无显著性差异(P〉0.05);临床疗效比较:疗程结束后,两组的总有效率分别为81.82%和95.35%,与对照组比较有显著性差异(P〈0.05)。结论结核丸联合抗结核药治疗糖尿病合并肺结核疗效显著,值得临床推广。
|
关 键 词: | 糖尿病合并肺结核 结核丸 免疫调节剂 |
Effect of Chinese and Western Medicine Combined with Immunomodulation on Diabetes with Pulmonary Tuberculosis |
| |
Authors: | YU Hongjun LUO Fang ZHANG Fusheng |
| |
Institution: | YU Hongjun LUO Fang ZHANG Fusheng Department 3 of Internal Medicine,Zhejiang Province Longyou County People's Hospital,Longyou 324400,China |
| |
Abstract: | objective To investigate the immune function,sputum conversion rate,closure rate of pore and the clinical efficacy of Chinese and western medicine combined with immunomodulation on diabetes with pulmonary tuberculosis(DPT).Methods Eighty-seven cases of DPT were randomly divided into treatment group(43 cases)and control group(44 cases).The control group received diet control,oral antidiabetic drug and the 2S(E)HRZ/4H3R3 chemotherapy regimen.The treatment group was given tuberculosis pills and immunomodifier ... |
| |
Keywords: | Diabetes with pulmonary tuberculosis Tuberculosis pills Immunomodifier |
本文献已被 CNKI 维普 万方数据 等数据库收录! |